A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
Study Identifier
M02-403
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
Phase
CSR.ORG
Sex
Female & Male
Age
18 - 75 Years
Protocol Summary
Purpose of the study is to test whether adalimumab can induce clinical remission in subjects
with active Crohn's disease when compared to placebo (an inactive substance)
Study Locations
Location
Status
Location
Gastroenterology Associates of the East Bay
Berkeley, California, United States, 94705
Status
Not applicable
Location
Long Beach Gastroenterology Assoc.
Long Beach, California, United States, 90806
Status
Not applicable
Location
Sharp Rees-Stealy Medical Group
San Diego, California, United States, 92123
Status
Not applicable
Location
Gastroenterology Assoc. of Fairfield Co.
Bridgeport, Connecticut, United States, 06606
Status
Not applicable
Location
Cleveland Clinic Florida
Weston, Florida, United States, 33331
Status
Not applicable
Location
Shafran Gastroenterology Center
Winter Park, Florida, United States, 32789
Status
Not applicable
Showing {first} - {last} of {total} Results